EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.
Sasaki H, Okuda K, Shimizu S, Takada M, Kawahara M, Kitahara N, Okumura M, Matsumura A, Iuchi K, Kawaguchi T, Kubo A, Kawano O, Yukiue H, Yano M, Fujii Y.
Sasaki H, et al. Among authors: shimizu s.
J Cancer Res Clin Oncol. 2009 Feb;135(2):313-8. doi: 10.1007/s00432-008-0464-5. Epub 2008 Aug 23.
J Cancer Res Clin Oncol. 2009.
PMID: 18726117